Journal of Clinical Densitometry
Volume 11, Issue 1 , Pages 92-108 , January 2008

Vertebral Fracture Assessment: The 2007 ISCD Official Positions

  • John T. Schousboe

      Affiliations

    • Park Nicollet Health Services, Minneapolis, MN, USA
    • Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA
    • Task Force Chair.
    • Corresponding Author InformationAddress correspondence to: John T. Schousboe, MD, MS, Park Nicollet Health Services, 3800 Park Nicollet Blvd., Minneapolis, MN 55416.
    • ,
  • Tamara Vokes

      Affiliations

    • Division of Endocrinology, University of Chicago, Chicago, IL, USA
    • Task Force Member.
    • ,
  • Susan B. Broy

      Affiliations

    • Illinois Bone and Joint Institute, Park Ridge, IL, USA
    • Task Force Member.
    • ,
  • Lynne Ferrar

      Affiliations

    • University of Sheffield, Sheffield, UK
    • Task Force Member.
    • ,
  • Fergus McKiernan

      Affiliations

    • Center for Bone Diseases, Marshfield Clinic, Marshfield, WI, USA
    • Task Force Member.
    • ,
  • Christian Roux

      Affiliations

    • Publique-Hôpitaux de Paris, Université Paris-Descartes, Hôpital Cochin, Paris, France
    • Task Force Member.
    • ,
  • Neil Binkley

      Affiliations

    • University of Wisconsin, Madison, WI, USA
    • ISCD PDC Liaison.

Received 5 December 2007 ,Accepted 5 December 2007.

References 

  1. Melton LJ, Kan SH, Frye MA, et al. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989;129(5):1000–1011
  2. Melton LJ, Lane AW, Cooper C, et al. Prevalence and incidence of vertebral deformities. Osteoporos Int. 1993;3(3):113–119
  3. Bouxsein ML, Melton LJ, Riggs BL, et al. Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res. 2006;21(9):1475–1482
  4. Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int. 2000;11(8):680–687
  5. O'Neill TW, Felsenberg D, Varlow J, et al. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res. 1996;11(7):1010–1018
  6. Spector TD, McCloskey EV, Doyle DV, et al. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res. 1993;8(7):817–822
  7. Ismail AA, Cooper C, Felsenberg D, et al. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int. 1999;9(3):206–213
  8. Jones G, White C, Nguyen T, et al. Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women. Osteoporos Int. 1996;6(3):233–239
  9. Ling X, Cummings SR, Mingwei Q, et al. Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project. J Bone Miner Res. 2000;15(10):2019–2025
  10. Lau EM, Chan YH, Chan M, et al. Vertebral deformity in Chinese men: prevalence, risk factors, bone mineral density, and body composition measurements. Calcif Tissue Int. 2000;66(1):47–52
  11. Tsai K, Twu S, Chieng P, et al. Prevalence of vertebral fractures in Chinese men and women in urban Taiwanese communities. Calcif Tissue Int. 1996;59(4):249–253
  12. Jinbayashi H, Aoyagi K, Ross PD, et al. Prevalence of vertebral deformity and its associations with physical impairment among Japanese women: the Hizen-Oshima Study. Osteoporos Int. 2002;13(9):723–730
  13. Horikawa K, Kasai Y, Yamakawa T, et al. Prevalence of osteoarthritis, osteoporotic vertebral fractures, and spondylolisthesis among the elderly in a Japanese village. J Orthop Surg (Hong Kong). 2006;14(1):9–12
  14. Burger H, van Daele PL, Algra D, et al. Vertebral deformities as predictors of non-vertebral fractures. BMJ. 1994;309(6960):991–992
  15. Black DM, Arden NK, Palermo L, et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14(5):821–828
  16. Haentjens P, Autier P, Collins J, et al. Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am. 2003;85-A(10):1936–1943
  17. Ismail AA, Cockerill W, Cooper C, et al. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int. 2001;12(2):85–90
  18. Johnell O, Oden A, Caulin F, et al. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int. 2001;12(3):207–214
  19. Kanis JA, Johnell O, Oden A, et al. The risk and burden of vertebral fractures in Sweden. Osteoporos Int. 2004;15(1):20–26
  20. Melton LJ, Atkinson EJ, Cooper C, et al. Vertebral fractures predict subsequent fractures. Osteoporos Int. 1999;10(3):214–221
  21. Schousboe JT, Fink HA, Lui LY, et al. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture. J Bone Miner Res. 2006;21(10):1557–1564
  22. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721–739
  23. Ross PD, Genant HK, Davis JW, et al. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int. May 1993;3(3):120–126
  24. Ross PD, Davis JW, Epstein RS, et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114(11):919–923
  25. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128(10):793–800
  26. O'Neill TW, Cockerill W, Matthis C, et al. Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int. 2004;15(9):760–765
  27. Fink HA, Ensrud KE, Nelson DB, et al. Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT). Osteoporos Int. 2003;14(1):69–76
  28. Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone. 1993;14(Suppl 1):S89–S97
  29. Fink HA, Milavetz DL, Palermo L, et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa?. J Bone Miner Res. 2005;20(7):1216–1222
  30. Chappard C, Kolta S, Fechtenbaum J, et al. Clinical evaluation of spine morphometric X-ray absorptiometry. Br J Rheumatol. 1998;37(5):496–501
  31. Ferrar L, Eastell R. Identification of vertebral deformities in men: comparison of morphometric radiography and morphometric X-ray absorptiometry. Osteoporos Int. 1999;10(2):167–174
  32. Ferrar L, Jiang G, Barrington NA, et al. Identification of vertebral deformities in women: comparison of radiological assessment and quantitative morphometry using morphometric radiography and morphometric X-ray absorptiometry. J Bone Miner Res. 2000;15(3):575–585
  33. Genant HK, Li J, Wu CY, et al. Vertebral fractures in osteoporosis: a new method for clinical assessment. J Clin Densitom. 2000;3(3):281–290
  34. Greenspan SL, von Stetten E, Emond SK, et al. Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom. 2001;4(4):373–380
  35. Rea JA, Chen MB, Li J, et al. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of analysis precision in normal and osteoporotic subjects. Osteoporos Int. 1999;9(6):536–544
  36. Rea JA, Li J, Blake GM, et al. Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int. 2000;11(8):660–668
  37. Rea JA, Chen MB, Li J, et al. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res. 2000;15(3):564–574
  38. Rea JA, Chen MB, Li J, et al. Vertebral morphometry: a comparison of long-term precision of morphometric X-ray absorptiometry and morphometric radiography in normal and osteoporotic subjects. Osteoporos Int. 2001;12(2):158–166
  39. Binkley N, Krueger D, Gangnon R, et al. Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int. 2005;16(12):1513–1518
  40. Schousboe JT, DeBold CR, Bowles C, et al. Prevalence of vertebral compression fracture deformity by X-ray absorptiometry of lateral thoracic and lumbar spines in a population referred for bone densitometry. J Clin Densitom. 2002;5(3):239–246
  41. Schousboe JT, Debold CR. Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int. 2006;17(2):281–289
  42. Vokes TJ, Dixon LB, Favus MJ. Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int. 2003;14(11):871–878
  43. Damiano J, Kolta S, Porcher R, et al. Diagnosis of vertebral fractures by vertebral fracture assessment. J Clin Densitom. 2006;9(1):66–71
  44. Vokes T, Bachman D, Baim S, et al. Vertebral fracture assessment: the 2005 ISCD Official Positions. J Clin Densitom. 2006;9(1):37–46
  45. Hartl F, Tyndall A, Kraenzlin M, et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the Basel Osteoporosis Study. J Bone Miner Res. 2002;17(2):321–330
  46. Lunt M, Felsenberg D, Reeve J, et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res. 1997;12(11):1883–1894
  47. Kaptoge S, Armbrecht G, Felsenberg D, et al. When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2004;19(12):1982–1993
  48. Yu W, Gluer CC, Grampp S, et al. Spinal bone mineral assessment in postmenopausal women: a comparison between dual X-ray absorptiometry and quantitative computed tomography. Osteoporos Int. 1995;5(6):433–439
  49. Jergas M, Genant HK. Spinal and femoral DXA for the assessment of spinal osteoporosis. Calcif Tissue Int. 1997;61(5):351–357
  50. Dey A, McCloskey EV, Taube T, et al. Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk. Osteoporos Int. 2000;11(11):953–958
  51. Huang C, Ross PD, Fujiwara S, et al. Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii. Bone. 1996;18(5):437–442
  52. Bauer DC, Gluer CC, Genant HK, et al. Quantitative ultrasound and vertebral fracture in postmenopausal women. Fracture Intervention Trial Research Group. J Bone Miner Res. 1995;10(3):353–358
  53. Frost ML, Blake GM, Fogelman I. Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria. Osteoporos Int. 1999;10(6):441–449
  54. Leidig-Bruckner G, Limberg B, Felsenberg D, et al. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women. Osteoporos Int. 2000;11(2):102–119
  55. Lang TF, Guglielmi G, van Kuijk C, et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone. 2002;30(1):247–250
  56. Mikhail MB, Flaster E, Aloia JF. Stiffness in discrimination of patients with vertebral fractures. Osteoporos Int. 1999;9(1):24–28
  57. Vogt TM, Ross PD, Palermo L, et al. Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group. Mayo Clin Proc. 2000;75(9):888–896
  58. Vokes TJ, Gillen DL, Pham AT, et al. Risk factors for prevalent vertebral fractures in black and white female densitometry patients. J Clin Densitom. 2007;10(1):1–9
  59. Kaptoge S, Armbrecht G, Felsenberg D, et al. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int. 2006;17(9):1369–1381
  60. Quandt SA, Thompson DE, Schneider DL, et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005;80(3):343–349
  61. Kanis JA, Johnell O, Black DM, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone. 2003;33(3):293–300
  62. Kanis JA, Barton IP, Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int. 2005;16(5):475–482
  63. Schousboe JT, Ensrud KE, Nyman JA, et al. Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>−2.5 for alendronate therapy: a modeling study. J Clin Densitom. 2006;9(2):133–143
  64. Schousboe JT, Nyman JA, Kane RL, et al. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med. 2005;142(9):734–741
  65. Olenginski TP, Newman ED, Hummel JL, et al. Development and evaluation of a vertebral fracture assessment program using IVA and its integration with mobile DXA. J Clin Densitom. 2006;9(1):72–77
  66. Brown JP, Josse RG. clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002;167(10 Suppl):S1–S34
  67. ACOG CoP . ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Osteoporosis. Number 50, January 2003. Obstet Gynecol. 2004;103(1):203–216
  68. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9(6):544–564
  69. Foundation NO . Physician guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org/physguide/index.htmAccessed January 15, 2005
  70. Meunier PJ, Delmas PD, Eastell R, et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther. 1999;21(6):1025–1044
  71. North AMS. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause. 2002;9(2):84–101
  72. Siris ES, Genant HK, Laster AJ, et al. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18(6):761–770
  73. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–1441
  74. Finkelstein JS, Hayes A, Hunzelman JL, et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med. 2003;349(13):1216–1226
  75. Body JJ, Gaich GA, Scheele WH, et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2002;87(10):4528–4535
  76. Miller PD, Shergy WJ, Body JJ, et al. Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol. 2005;32(8):1556–1562
  77. Liu H, Michaud K, Nayak S, et al. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med. 2006;166(11):1209–1217
  78. Lundkvist J, Johnell O, Cooper C, et al. Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women. Osteoporos Int. 2006;17(2):201–211
  79. Colon-Emeric CS. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA. 2006;296(24):2968–2969
  80. Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006;296(24):2927–2938
  81. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285(3):320–323
  82. Genant HK, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11(7):984–996
  83. Chesnut IC, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19(8):1241–1249
  84. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14):1344–1352
  85. Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000;11(1):83–91
  86. Seeman E, Compston J, Adachi J, et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int. 2007;18(6):711–719
  87. Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int. 2007;18(8):1023–1031
  88. Recker RR, Gallagher R, MacCosbe PE. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc. 2005;80(7):856–861
  89. Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013–1022
  90. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med. 2005;165(20):2414–2419
  91. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone. 2006;38(6):922–928
  92. Lo JC, Pressman AR, Omar MA, et al. Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006;17(6):922–928
  93. McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas. 2004;48(3):271–287
  94. Rossini M, Bianchi G, Di Munno O, et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int. 2006;17(6):914–921
  95. Ettinger MP, Gallagher R, MacCosbe PE. Medication persistence with weekly versus daily doses of orally administered bisphosphonates. Endocr Pract. 2006;12(5):522–528
  96. Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004;15(12):1003–1008
  97. Pressman A, Forsyth B, Ettinger B, et al. Initiation of osteoporosis treatment after bone mineral density testing. Osteoporos Int. 2001;12(5):337–342
  98. Silverman SL, Greenwald M, Klein RA, et al. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol. 1997;89(3):321–325
  99. Pickney CS, Arnason JA. Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int. 2005;16(9):1156–1160
  100. Carr AJ, Thompson PW, Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int. 2006;17(11):1638–1644
  101. Ettinger B, Black DM, Nevitt MC, et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1992;7(4):449–456
  102. Johnell O, O'Neill T, Felsenberg D, et al. Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol. 1997;146(4):287–293
  103. Nevitt MC, Cummings SR, Stone KL, et al. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res. 2005;20(1):131–140
  104. Jacobs-Kosmin D, Sandorfi N, Murray H, et al. Vertebral deformities identified by vertebral fracture assessment: associations with clinical characteristics and bone mineral density. J Clin Densitom. 2005;8(3):267–272
  105. Eisman J, Clapham S, Kehoe L. Osteoporosis prevalence and levels of treatment in primary care: the Australian Bone Care Study. J Bone Miner Res. 2004;19(12):1969–1975
  106. Gunnes M, Lehmann EH, Mellstrom D, et al. The relationship between anthropometric measurements and fractures in women. Bone. 1996;19(4):407–413
  107. Siminoski K, Warshawski RS, Jen H, et al. The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women. Osteoporos Int. 2006;17(2):290–296
  108. Tobias JH, Hutchinson AP, Hunt LP, et al. Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int. 2007;18(1):35–43
  109. Papaioannou A, Joseph L, Ioannidis G, et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2005;16(5):568–578
  110. Krege JH, Siminoski K, Adachi JD, et al. A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis. Osteoporos Int. 2006;17(3):379–386
  111. Siminoski K, Jiang G, Adachi JD, et al. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int. 2005;16(4):403–410
  112. Roux C, Priol G, Fechtenbaum J, et al. A clinical tool to determine the necessity of spine radiography in postmenopausal women with osteoporosis presenting with back pain. Ann Rheum Dis. 2007;66(1):81–85
  113. Gallacher SJ, Gallagher AP, McQuillian C, et al. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int. 2007;18(2):185–192
  114. Schousboe JT, Fink HA, Taylor BC, et al. Association between self-reported prior wrist fractures and risk of subsequent hip and radiographic vertebral fractures in older women: a prospective study. J Bone Miner Res. 2005;20(1):100–106
  115. Bagger YZ, Tanko LB, Alexandersen P, et al. The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study. Osteoporos Int. 2006;17(3):471–477
  116. Wasnich RD, Davis JW, Ross PD. Spine fracture risk is predicted by non-spine fractures. Osteoporos Int. 1994;4(1):1–5
  117. van der Klift M, de Laet CE, McCloskey EV, et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res. 2004;19(7):1172–1180
  118. Delmas PD, Genant HK, Crans GG, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone. 2003;33(4):522–532
  119. Van der Klift M, De Laet CE, McCloskey EV, et al. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res. 2002;17(6):1051–1056
  120. McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3 Pt 1):704–709
  121. Lespessailles E, Poupon S, Adriambelosoa N, et al. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?. Joint Bone Spine. 2000;67(2):119–126
  122. Van Staa TP, Laan RF, Barton IP, et al. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48(11):3224–3229
  123. de Nijs RN, Jacobs JW, Bijlsma JW, et al. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology (Oxford). 2001;40(12):1375–1383
  124. Naganathan V, Jones G, Nash P, et al. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med. 2000;160(19):2917–2922
  125. Lems WF, Jahangier ZN, Jacobs JW, et al. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol. 1995;13(3):293–297
  126. Peel NF, Moore DJ, Barrington NA, et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995;54(10):801–806
  127. Tsugeno H, Fujita T, Goto B, et al. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis. Osteoporos Int. 2002;13(8):650–656
  128. Arai K, Hanyu T, Sugitani H, et al. Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab. 2006;24(2):118–124
  129. Bultink IE, Lems WF, Kostense PJ, et al. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(7):2044–2050
  130. Stockbrugger RW, Schoon EJ, Bollani S, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther. 2002;16(8):1519–1527
  131. Laan RF, van Riel PL, van Erning LJ, et al. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol. 1992;31(2):91–96
  132. van Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, et al. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?. Clin Exp Rheumatol. 2003;21(2):155–160
  133. Walsh LJ, Lewis SA, Wong CA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med. 2002;166(5):691–695
  134. Walsh LJ, Wong CA, Oborne J, et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax. 2001;56(4):279–284
  135. Orstavik RE, Haugeberg G, Mowinckel P, et al. Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med. 2004;164(4):420–425
  136. Dykman TR, Gluck OS, Murphy WA, et al. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1985;28(4):361–368
  137. Michel BA, Bloch DA, Wolfe F, et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol. 1993;20(10):1666–1669
  138. Sinigaglia L, Nervetti A, Mela Q, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol. 2000;27(11):2582–2589
  139. Giannini S, Nobile M, Dalle Carbonare L, et al. Vertebral morphometry by X-ray absorptiometry before and after liver transplant: a cross-sectional study. Eur J Gastroenterol Hepatol. 2001;13(10):1201–1207
  140. Angeli A, Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone. 2006;39(2):253–259
  141. Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut. 2002;51(5):654–658
  142. Melton LJ, Patel A, Achenbach SJ, et al. Long-term fracture risk following adult-onset asthma: a population-based study. Osteoporos Int. 2004;15(4):311–316
  143. Melton LJ, Patel A, Achenbach SJ, et al. Long-term fracture risk among children with asthma: a population-based study. J Bone Miner Res. 2005>;20(4):564–570
  144. De Vries F, Bracke M, Leufkens HG, et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56(1):208–214
  145. van Staa TP, Cooper C, Brusse LS, et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology. 2003;125(6):1591–1597
  146. van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39(12):1383–1389
  147. Van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15(6):993–1000
  148. Orstavik RE, Haugeberg G, Uhlig T, et al. Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry. Osteoporos Int. 2005;16(1):35–42
  149. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19(6):893–899
  150. Kumagai S, Kawano S, Atsumi T, et al. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol. 2005;32(5):863–869
  151. Luengo M, Picado C, Del Rio L, et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 1991;46(11):803–806
  152. Hirano Y, Kishimoto H, Hagino H, et al. The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab. 1999;17(2):119–124
  153. Kaji H, Tobimatsu T, Naito J, et al. Body composition and vertebral fracture risk in female patients treated with glucocorticoid. Osteoporos Int. 2006;17(4):627–633
  154. Evans SF, Davie MW. Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis. 2000;59(4):269–275
  155. Tsugeno H, Goto B, Fujita T, et al. Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients. Osteoporos Int. 2001;12(4):266–270
  156. Steinbuch M, Youket TE, Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int. 2004;15(4):323–328
  157. Mitra D, Elvins DM, Speden DJ, et al. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford). 2000;39(1):85–89
  158. Santavirta S, Konttinen YT, Heliovaara M, et al. Determinants of osteoporotic thoracic vertebral fracture. Screening of 57,000 Finnish women and men. Acta Orthop Scand. 1992;63(2):198–202
  159. Vallarta-Ast N, Krueger D, Wrase C, et al. An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int. 2007;18(10):1405–1410
  160. Lunt M, O'Neill TW, Felsenberg D, et al. Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). Bone. 2003;33(4):505–513
  161. Felsenberg D, Silman A, Lunt M, et al. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2002;17(4):716–724
  162. Greenspan SL, Coates P, Sereika SM, et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab. 2005;90(12):6410–6417
  163. Daniell HW, Dunn SR, Ferguson DW, et al. Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol. 2000;163(1):181–186
  164. Diamond TH, Higano CS, Smith MR, et al. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer. 2004;100(5):892–899
  165. Smith MR. Treatment-related osteoporosis in men with prostate cancer. Clin Cancer Res. 2006;12(20 Pt 2):6315s–6319s
  166. Lopez AM, Pena MA, Hernandez R, et al. Fracture risk in patients with prostate cancer on androgen deprivation therapy. Osteoporos Int. 2005;16(6):707–711
  167. Shahinian VB, Kuo YF, Freeman JL, et al. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154–164
  168. Smith MR, Lee WC, Brandman J, et al. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol. 2005;23(31):7897–7903
  169. Smith MR, Boyce SP, Moyneur E, et al. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol. 2006;175(1):136–139[discussion 139]
  170. Melton LJ, Alothman KI, Khosla S, et al. Fracture risk following bilateral orchiectomy. J Urol. 2003;169(5):1747–1750
  171. Diamond TH, Bucci J, Kersley JH, et al. Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy. J Urol. 2004;172(2):529–532
  172. Makitie O, Doria AS, Henriques F, et al. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr. 2005;146(3):395–401
  173. Valta H, Lahdenne P, Jalanko H, et al. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34(4):831–836
  174. Helenius I, Remes V, Salminen S, et al. Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res. 2006;21(3):380–387
  175. Cooper C, Atkinson EJ, O'Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7(2):221–227
  176. Ziegler R, Scheidt-Nave C, Leidig-Bruckner G. What is a vertebral fracture?. Bone. 1996;18(3 Suppl):169S–177S
  177. O'Neill TW, Silman AJ. Definition and diagnosis of vertebral fracture. J Rheumatol. 1997;24(6):1208–1211
  178. Hurxthal LM, Vose GP, Dotter WE. Densitometric and visual observations of spinal radiographs. Geriatrics. 1969;24(5):93–106
  179. Hedlund LR, Gallagher JC. Vertebral morphometry in diagnosis of spinal fractures. Bone Miner. 1988;5(1):59–67
  180. Harma M, Heliovaara M, Aromaa A, et al. Thoracic spine compression fractures in Finland. Clin Orthop. 1986;(205):188–194
  181. Ross PD, Davis JW, Epstein RS, et al. Ability of vertebral dimensions from a single radiograph to identify fractures. Calcif Tissue Int. 1992;51(2):95–99
  182. Gallagher JC, Hedlund LR, Stoner S, et al. Vertebral morphometry: normative data. Bone Miner. 1988;4(2):189–196
  183. Raymakers JA, Kapelle JW, van Beresteijn EC, et al. Assessment of osteoporotic spine deformity. A new method. Skeletal Radiol. 1990;19(2):91–97
  184. Minne HW, Leidig G, Wuster C, et al. A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner. 1988;3(4):335–349
  185. McCloskey EV, Spector TD, Eyres KS, et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int. 1993;3(3):138–147
  186. Black DM, Cummings SR, Stone K, et al. A new approach to defining normal vertebral dimensions. J Bone Miner Res. 1991;6(8):883–892
  187. Eastell R, Cedel SL, Wahner HW, et al. Classification of vertebral fractures. J Bone Miner Res. 1991;6(3):207–215
  188. Grados F, Roux C, de Vernejoul MC, et al. Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int. 2001;12(9):716–722
  189. Wu CY, Li J, Jergas M, et al. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int. 1995;5(5):354–370
  190. Black DM, Palermo L, Nevitt MC, et al. Comparison of methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res. 1995;10(6):890–902
  191. Smith-Bindman R, Cummings SR, Steiger P, et al. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res. 1991;6(1):25–34
  192. Ferrar L, Jiang G, Adams J, et al. Identification of vertebral fractures: an update. Osteoporos Int. 2005;16(7):717–728
  193. Genant HK, Jergas M. Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporos Int. 2003;14(Suppl 3):S43–S55
  194. Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137–1148
  195. Antoniou J, Nguyen C, Lander P, et al. Osteoporosis of the spine: correlation between vertebral deformity and bone mineral density in postmenopausal women. Am J Orthop. 2000;29(12):956–959
  196. Vokes TJ, Gillen DL, Lovett J, et al. Comparison of T-scores from different skeletal sites in differentiating postmenopausal women with and without prevalent vertebral fractures. J Clin Densitom. 2005;8(2):206–215
  197. Abdel-Hamid Osman A, Bassiouni H, Koutri R, et al. Aging of the thoracic spine: distinction between wedging in osteoarthritis and fracture in osteoporosis–a cross-sectional and longitudinal study. Bone. 1994;15(4):437–442
  198. Szulc P, Munoz F, Marchand F, et al. Semiquantitative evaluation of prevalent vertebral deformities in men and their relationship with osteoporosis: the MINOS study. Osteoporos Int. 2001;12(4):302–310
  199. Ito Z, Harada A, Matsui Y, et al. Can you diagnose for vertebral fracture correctly by plain X-ray?. Osteoporos Int. 2006;17(11):1584–1591
  200. Crans GG, Genant HK, Krege JH. Prognostic utility of a semiquantitative spinal deformity index. Bone. 2005;37(2):175–179
  201. Ferrar L, Jiang G, Eastell R, et al. Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry. J Bone Miner Res. 2003;18(5):933–938
  202. Jiang G, Eastell R, Barrington NA, et al. Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int. 2004;15(11):887–896
  203. Ferrar L, Jiang G, Armbrecht G, et al. Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). Bone. 2007;41(1):5–12
  204. Ferrar L, Jiang G, Cawthon PM, et al. Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study. J Bone Miner Res. 2007;22(9):1434–1441
  205. Ferrar L, Jiang G, Schousboe JT, et al. Algorithm-based qualitative and seniqualitative indentification of prevalent vertebral fracture: agreement between different traders imaging modalities and diagnostic approaches. J Bone Miner Res. 2007;[epub]
  206. Pavlov L, Gamble GD, Reid IR. Comparison of dual-energy x-ray absorptiometry and conventional radiography for the detection of vertebral fractures. J Clin Densitom. 2005;8(4):379–385
  207. Ferrar L, Jiang G, Eastell R. Short-term precision for morphometric X-ray absorptiometry. Osteoporos Int. 2001;12(9):710–715
  208. Rea JA, Steiger P, Blake GM, et al. Optimizing data acquisition and analysis of morphometric X-ray absorptiometry. Osteoporos Int. 1998;8(2):177–183
  209. Hasserius R, Redlund-Johnell I, Mellstrom D, et al. Vertebral deformation in urban Swedish men and women: prevalence based on 797 subjects. Acta Orthop Scand. 2001;72(3):273–278
  210. Vallarta-Ast N, Krueger D, Binkley N. Addition of right lateral decubitus positioning improves vertebral visualization with VFA in selected patients. J Clin Densitom. 2006;9(3):375–379
  211. Chan KK, Sartoris DJ, Haghighi P, et al. Cupid's bow contour of the vertebral body: evaluation of pathogenesis with bone densitometry and imaging-histopathologic correlation. Radiology. 1997;202(1):253–256
  212. Hilton RC, Ball J, Benn RT. Vertebral end-plate lesions (Schmorl's nodes) in the dorsolumbar spine. Ann Rheum Dis. 1976;35(2):127–132
  213. Lecuyer N, Grados F, Dargent-Molina P, et al. Prevalence of Paget's disease of bone and spinal hemangioma in French women older than 75 years: data from the EPIDOS study. Joint Bone Spine. 2000;67(4):315–318
  214. Harrington KD. Vertebral compression fractures: differentiation between benign and malignant causes. Iowa Orthop J. 1993;13:85–96
  215. Fornasier VL, Czitrom AA. Collapsed vertebrae: a review of 659 autopsies. Clin Orthop Relat Res. 1978;(131):261–265
  216. Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine. 1990;15(1):1–4
  217. Haller J, Andre MP, Resnick D, et al. Detection of thoracolumbar vertebral body destruction with lateral spine radiography. Part II: clinical investigation with computed tomography. Invest Radiol. 1990;25(5):523–532
  218. Schneider DL, Bettencourt R, Barrett-Connor E. Clinical utility of spine bone density in elderly women. J Clin Densitom. 2006;9(3):255–260
  219. Wilson PW, Kauppila LI, O'Donnell CJ, et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 2001;103(11):1529–1534
  220. van der Meer IM, Bots ML, Hofman A, et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109(9):1089–1094
  221. Schousboe JT, Taylor BC, Kiel DP, et al. 2007 Abdominal aortic calcification (AAC) on vertebral fracture assessment images predicts incident myocardial infarction or stroke independent of clinical cardiovascular disease risk factors. J Bone Miner Res [e pub].
  222. Hollander M, Hak AE, Koudstaal PJ, et al. Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke. 2003;34(10):2367–2372
  223. Walsh CR, Cupples LA, Levy D, et al. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study. Am Heart J. 2002;144(4):733–739
  224. Schousboe JT, Wilson KE, Hangartner TN. Detection of aortic calcification during vertebral fracture assessment (VFA) compared to digital radiography. PLoS ONE. 2007;2(1):e715
  225. Ginsberg MD. Beyond the viewbox: the radiologist's duty to communicate findings. John Marshall Law Rev. 2002;35:359–380
  226. Berlin L. Defending the “missed” radiographic diagnosis. AJR Am J Roentgenol. 2001;176(2):317–322
  227. Wu C, van Kuijk C, Li J, et al. Comparison of digitized images with original radiography for semiquantitative assessment of osteoporotic fractures. Osteoporos Int. 2000;11(1):25–30
  228. Sauer P, Leidig G, Minne HW, et al. Spine deformity index (SDI) versus other objective procedures of vertebral fracture identification in patients with osteoporosis: a comparative study. J Bone Miner Res. 1991;6(3):227–238
  229. Herss Nielsen VA, Podenphant J, Martens S, et al. Precision in assessment of osteoporosis from spine radiographs. Eur J Radiol. 1991;13(1):11–14

PII: S1094-6950(07)00256-9

doi: 10.1016/j.jocd.2007.12.008

Journal of Clinical Densitometry
Volume 11, Issue 1 , Pages 92-108 , January 2008

Article Tools